Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 9/20 | 0.41 |
| ▸ | PPARG | P37231 | 8/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | EDNRB | P24530 | 2/20 | 0.39 |
| ▸ | EDNRA | P25101 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL28597924 | 0.97 | ALOX15 (0.41) | ALOX15PPARAPPARGMTNR1AMTNR1B | |
| SCHEMBL28599039 | 0.86 | PPARA (0.38) | ALOX15PPARAPPARGMTNR1AMTNR1B | |
| SCHEMBL2046224 | 0.85 | ALOX15 (0.44) | ALOX15PPARAPPARGMTNR1AMTNR1B | |
| SCHEMBL7037791 | 0.80 | ATM (0.47) | PPARAPPARGMTNR1AMTNR1BCYP1A2 | |
| SCHEMBL5503297 | 0.76 | EDNRB (0.44) | ALOX15PPARAPPARGMTNR1AMTNR1B | |
| SCHEMBL6699933 | 0.75 | PPARG (0.40) | PPARAPPARGMTNR1AMTNR1BCYP1A2 | |
| SCHEMBL7322928 | 0.74 | ATM (0.49) | PPARAPPARGMTNR1AMTNR1BCYP1A2 | |
| SCHEMBL22260771 | 0.73 | MTNR1A (0.34) | PPARAPPARGMTNR1AMTNR1BCYP1A2 | |
| SCHEMBL1577777 | 0.73 | CYP1A2 (0.46) | PPARAPPARGMTNR1AMTNR1BCYP1A2 | |
| SCHEMBL8132529 | 0.72 | PPARA (0.40) | ALOX15PPARAPPARGMTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023168066-A9 | OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE | CONAGEN INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| EP-4337639-A1 | NAMPT INHIBITORS AND USES THEREOF | Remedy Plan, Inc. (US) | 2024-03-20 | — | — | EP | disclosed |
| WO-2023201005-A2 | HYDROPHOBIC POLYMER AEROGELS | AEROGEL TECHNOLOGIES, LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023168066-A1 | OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE | CONAGEN INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023168045-A1 | HYDROXY/AMINO OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE | CONAGEN INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| US-20230158159-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-25 | — | — | US | disclosed |
| CN-114604951-B | Application of p-tert-octyl phenoxy carboxylic acid in copper-containing wastewater treatment | 厦门稀土材料研究所 | 2023-05-09 | — | — | CN | disclosed |
| CN-113201649-B | Phenoxy carboxylic acid solid-phase extracting agent, and preparation method and application thereof | 福建省长汀金龙稀土有限公司 | 2023-04-11 | — | — | CN | disclosed |
| WO-2022241257-A1 | NAMPT INHBITORS AND USES THEREOF | REMEDY PLAN, INC. (US) | 2022-11-17 | — | — | WO | disclosed |
| CN-114604951-A | Application of p-tert-octyl phenoxy carboxylic acid in copper-containing wastewater treatment | 厦门稀土材料研究所 | 2022-06-10 | — | — | CN | disclosed |
| WO-2018067973-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2018-04-12 | — | — | WO | disclosed |
| WO-2017192664-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2017-11-09 | — | — | WO | disclosed |
| WO-2017192679-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | WAVE LIFE SCIENCES LTD. (SG) | 2017-11-09 | — | — | WO | disclosed |
| EP-3234175-A1 | ENZYMATIC ACTIVITY ASSAYS FOR I2S | Shire Human Genetic Therapies, Inc. (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2017062862-A2 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2017-04-13 | — | — | WO | disclosed |
| WO-2017062622-A1 | SUPRAMOLECULAR MODIFICATION OF PROTEINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-04-13 | — | — | WO | disclosed |
| WO-2017015555-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2017-01-26 | — | — | WO | disclosed |
| WO-2017015575-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2017-01-26 | — | — | WO | disclosed |
| WO-2016100603-A9 | ENZYMATIC ACTIVITY ASSAYS FOR I2S | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2016-08-11 | — | — | WO | disclosed |
| WO-2016100603-A1 | ENZYMATIC ACTIVITY ASSAYS FOR I2S | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158159-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | CDK9, CDK19, CRBN | ALOX15 4637/4885PPARA 3922/4885PPARG 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.